Molecular Partners AG
MLLCF
$2.25
-$0.10-4.25%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -4.79% | -17.11% | -10.32% | -17.80% | -20.01% |
| Gross Profit | 4.79% | 11.57% | -1.74% | -2.01% | 12.42% |
| SG&A Expenses | -7.83% | -11.61% | -1.39% | -8.61% | -6.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.89% | -15.53% | -8.06% | -15.58% | -15.63% |
| Operating Income | 5.89% | 11.58% | -0.87% | 1.00% | 10.40% |
| Income Before Tax | -23.77% | 21.98% | -48.26% | -44.04% | 42.75% |
| Income Tax Expenses | 117.39% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.79% | 21.98% | -48.26% | -44.03% | 42.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.79% | 21.98% | -48.26% | -44.03% | 42.74% |
| EBIT | 5.89% | 11.58% | -0.87% | 1.00% | 10.40% |
| EBITDA | 5.99% | 11.92% | -0.88% | 0.59% | 10.65% |
| EPS Basic | -22.03% | 30.77% | -31.58% | -28.37% | 48.99% |
| Normalized Basic EPS | -22.43% | 31.45% | -14.71% | -28.38% | 49.00% |
| EPS Diluted | -21.30% | 30.77% | -31.58% | -28.37% | 48.68% |
| Normalized Diluted EPS | -22.43% | 31.45% | -14.71% | -28.38% | 49.00% |
| Average Basic Shares Outstanding | 1.44% | 12.67% | 12.69% | 12.19% | 12.26% |
| Average Diluted Shares Outstanding | 1.44% | 12.67% | 12.69% | 12.19% | 12.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |